AngioDynamics, Inc.
ANGO
$12.34
$0.342.83%
NASDAQ
| 08/31/2025 | 05/31/2025 | 02/28/2025 | 11/30/2024 | 08/31/2024 | |
|---|---|---|---|---|---|
| Revenue | 75.71M | 80.16M | 72.00M | 72.85M | 67.49M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 75.71M | 80.16M | 72.00M | 72.85M | 67.49M |
| Cost of Revenue | 33.85M | 37.94M | 33.15M | 32.94M | 30.77M |
| Gross Profit | 41.86M | 42.22M | 38.86M | 39.91M | 36.72M |
| SG&A Expenses | 40.78M | 36.76M | 36.08M | 36.07M | 36.69M |
| Depreciation & Amortization | 2.65M | 2.59M | 2.60M | 2.56M | 2.57M |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 83.61M | 83.79M | 78.65M | 77.92M | 76.20M |
| Operating Income | -7.90M | -3.63M | -6.65M | -5.07M | -8.71M |
| Income Before Tax | -10.84M | -6.11M | -4.41M | -10.85M | -12.67M |
| Income Tax Expenses | 65.00K | -60.00K | -2.00K | -110.00K | 133.00K |
| Earnings from Continuing Operations | -10.90M | -6.05M | -4.41M | -10.74M | -12.80M |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -10.90M | -6.05M | -4.41M | -10.74M | -12.80M |
| EBIT | -7.90M | -3.63M | -6.65M | -5.07M | -8.71M |
| EBITDA | -1.88M | -1.20M | -329.00K | 1.79M | -1.93M |
| EPS Basic | -0.26 | -0.15 | -0.11 | -0.26 | -0.31 |
| Normalized Basic EPS | -0.12 | -0.06 | -0.02 | -0.07 | -0.13 |
| EPS Diluted | -0.26 | -0.15 | -0.11 | -0.26 | -0.31 |
| Normalized Diluted EPS | -0.12 | -0.06 | -0.02 | -0.07 | -0.13 |
| Average Basic Shares Outstanding | 41.17M | 40.98M | 40.85M | 40.92M | 40.65M |
| Average Diluted Shares Outstanding | 41.17M | 40.98M | 40.85M | 40.92M | 40.65M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |